De Mattos-Arruda et al. found mutations in IDH1/2, EGFR, PTEN, FGFR2, and ERBB2 genes, and they showed that CSF-ctDNA undergoes dynamic changes that are correlated with the treatment course of patients with glioblastoma [117]. The gene discussed is EGFR; the disease is glioblastoma.